GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31

Guardian Pharmacy Services, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$40.14+0.67 (+1.70%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Guardian Pharmacy Services, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31
Revenue	1,449	1,228
Cost of Revenue	1,156	984
Gross Profit	293	244
Selling, General & Admin	220	307
Advertising Expenses	3.90	3.50
Operating Income	73	-63
Interest Expense	0.67	3.28
Other Non-Operating Income	0.72	-3.56
Asset Impairment Charges	0	–
Pretax Income	73	-66
Income Tax Expense	24	4.56
Income from Continuing Operations	49	-71
Net Income incl. Noncontrolling Interests	49	-71
Minority Interest in Earnings	-0.26	16
Net Income	49	-110
EBITDA	95	-43

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 21.6%
Operating margin: 5.8%
Net margin: 4.5%
Return on equity, FY2025: –

Financial strength

Current ratio: 1.65
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 58.3%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –